dexrazoxane has been researched along with Hematologic Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badalamenti, G; Improta, L; Mazzocca, A; Napolitano, A; Santini, D; Silletta, M; Spalato Ceruso, M; Tonini, G; Valeri, S; Vincenzi, B | 1 |
1 other study(ies) available for dexrazoxane and Hematologic Diseases
Article | Year |
---|---|
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Dexrazoxane; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Protective Agents; Retrospective Studies; Sarcoma; Young Adult | 2019 |